Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

Milestone Pharmaceuticals Closes $55 Million Series C Financing

Milestone Pharmaceuticals, August 1, 2017 – Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular company, today announced the completion of a US$55 million Series C financing. The round was led by Novo Holdings A/S, and included new investors Forbion Capital Partners and funds managed by Tekla Capital Management, with significant participation from Milestone's existing investors Domain Associates, Fonds de solidarité FTQ, BDC Capital, Pappas Capital, and GO Capital.

Learn more

Share